慢性淋巴细胞白血病的蛋白质图谱
研究用数据非依赖采集质谱分析了117例慢性淋巴细胞白血病(CLL)患者样本的蛋白质组,整合基因组、转录组、离体药物反应和临床结局数据,发现12三体、IGHV突变状态、SF3B1突变等影响蛋白表达,12三体和IGHV状态是蛋白表达变异的主要决定因素,STAT2蛋白表达与激酶抑制剂反应相关。
要点
- 12三体和IGHV状态是CLL蛋白表达变异的主要决定因素。
- 12三体CLL中BCR/PI3K/AKT信号通路被提示为肿瘤驱动因素。
- STAT2蛋白表达与激酶抑制剂(包括BTK和MEK抑制剂)反应相关。
核心结论
- 蛋白丰度数据是肿瘤生物学中非冗余的信息层,本研究为CLL提供了蛋白表达参考图谱。
研究设计与样本
- 研究用数据非依赖采集质谱分析了117例CLL患者样本的蛋白质组,并整合基因组、转录组、离体药物反应和临床结局数据。
主要发现
- 12三体、IGHV突变状态、SF3B1突变、19三体、del(17)(p13)、del(11)(q22.3)、DDX3X突变和MED12突变影响蛋白表达(FDR=5%)。
- 主成分分析显示12三体和IGHV状态是CLL蛋白表达变异的主要决定因素(分别有1055和542个差异表达蛋白,FDR=5%)。
- 12三体CLL的基因集富集分析提示BCR/PI3K/AKT信号通路为肿瘤驱动因素,蛋白丰度缓冲和蛋白复合物分析支持该发现。
- STAT2蛋白表达与激酶抑制剂(包括BTK和MEK抑制剂)反应相关,STAT2在未突变IGHV CLL和12三体CLL中上调,为趋化因子/细胞因子信号(干扰素反应)所需。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Many functional consequences of mutations on tumor phenotypes in chronic lymphocytic leukemia (CLL) are unknown. This may be in part due to a scarcity of information on the proteome of CLL. We profiled the proteome of 117 CLL patient samples with data-independent acquisition mass spectrometry and integrated the results with genomic, transcriptomic, ex vivo drug response, and clinical outcome data. We found trisomy 12, IGHV mutational status, mutated SF3B1, trisomy 19, del(17)(p13), del(11)(q22.3), mutated DDX3X and MED12 to influence protein expression (false discovery rate [FDR] = 5%). Trisomy 12 and IGHV status were the major determinants of protein expression variation in CLL as shown by principal-component analysis (1055 and 542 differentially expressed proteins, FDR = 5%). Gene set enrichment analyses of CLL with trisomy 12 implicated B-cell receptor (BCR)/phosphatidylinositol 3-kinase (PI3K)/AKT signaling as a tumor driver. These findings were supported by analyses of protein abundance buffering and protein complex formation, which identified limited protein abundance buffering and an upregulated protein complex involved in BCR, AKT, MAPK, and PI3K signaling in trisomy 12 CLL. A survey of proteins associated with trisomy 12/IGHV-independent drug response linked STAT2 protein expression with response to kinase inhibitors, including Bruton tyrosine kinase and mitogen-activated protein kinase kinase (MEK) inhibitors. STAT2 was upregulated in unmutated IGHV CLL and trisomy 12 CLL and required for chemokine/cytokine signaling (interferon response). This study highlights the importance of protein abundance data as a nonredundant layer of information in tumor biology and provides a protein expression reference map for CLL.
引用
- Meier-Abt F, Lu J, Cannizzaro E, et al. The protein landscape of chronic lymphocytic leukemia. Blood. 2021. PMID: 34189564. doi:10.1182/blood.2020009741
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。